CVD

DGAP-News: G Medical Innovations (NASDAQ: GMVD) is forecasting incremental Q1 revenues at around $30 MM, based on revenue generated from G Medical Tests and Services' physical storefront testing locations

Retrieved on: 
Friday, January 14, 2022 - 12:05pm

G Medical Innovations (NASDAQ: GMVD) is forecasting incremental Q1 revenues at around $30 MM, based on revenue generated from G Medical Tests and Services' physical storefront testing locations

Key Points: 
  • G Medical Innovations (NASDAQ: GMVD) is forecasting incremental Q1 revenues at around $30 MM, based on revenue generated from G Medical Tests and Services' physical storefront testing locations
    The issuer is solely responsible for the content of this announcement.
  • Dr. Yacov Geva, President and CEO of G Medical Innovations, and Michael McDade, CEO of McDade Products, LLC , announced today that they acquired an undisclosed number of shares of G Medical Innovations (NASDAQ: GMVD).
  • G Medical Tests and Services currently operates storefront testing locations in California.
  • During the next few months, the company expects to expand its network of storefront testing locations in California and other U.S. regions to be announced at a later date.

Victor Huang Joins Yield Engineering Systems (YES) as VP of Legal Affairs

Retrieved on: 
Friday, January 14, 2022 - 12:15am

FREMONT, Calif., Jan. 13, 2022 /PRNewswire-PRWeb/ --YES ( Yield Engineering Systems, Inc .

Key Points: 
  • FREMONT, Calif., Jan. 13, 2022 /PRNewswire-PRWeb/ --YES ( Yield Engineering Systems, Inc .
  • ), a leading manufacturer of process equipment for semiconductor advanced packaging, life sciences and "More-than-Moore" applications, today announced that Victor Huang has joined the company as its first Vice President of Legal Affairs.
  • Mr. Huang holds a bachelor's degree in Electrical Engineering from the University of California at Davis, and received his JD from the University of San Francisco School of Law.
  • YES (Yield Engineering Systems, Inc.) is a preferred provider of high-tech, cost-effective equipment for transforming surfaces, materials, and interfaces.

DGAP-News: McDade Products, LLC and G Medical Tests Secure Additional Purchase Order for $6.5 Million, Reflecting $3.5 Million Gross Margin, to be Delivered in Q1

Retrieved on: 
Wednesday, January 12, 2022 - 12:07pm

Secure Additional Purchase Order for $6.5 Million,

Key Points: 
  • Secure Additional Purchase Order for $6.5 Million,
    Reflecting $3.5 Million Gross Margin, to be Delivered in Q1
    The issuer is solely responsible for the content of this announcement.
  • PITTSBURGH, PA - McDade Products, LLC and G Medical Tests and Services, a division of G Medical Innovations Holdings Ltd. (NASDAQ: GMVD), today announced an additional $6.5 million purchase order for two million COVID-19 PCR collection test kits.
  • G Medical will be selling these units wholesale for $3.25 each, reflecting a gross profit of approximately $3.5 million.
  • G Medical Tests and Services is delighted to provide McDade with current and future purchase orders.

CVD Equipment Corporation Reports Increased Product Demand For 2021

Retrieved on: 
Tuesday, January 11, 2022 - 1:30pm

CVD Equipment Corporation (NASDAQ: CVV ), a leading provider of chemical vapor deposition systems, today announced increased product demand in 2021.

Key Points: 
  • CVD Equipment Corporation (NASDAQ: CVV ), a leading provider of chemical vapor deposition systems, today announced increased product demand in 2021.
  • CVD has seen order growth in all segments and products, including a 100% growth in the CVD equipment portion of the business, with 23 system orders in 2021.
  • The order rate has also increased in the SDC Division and CVD Materials Division which includes the Tantaline and MesoScribe product lines.
  • said Emmanuel Lakios, President and CEO of CVD Equipment Corporation.

Nails Coalition Files Brief Supporting U.S. Government in Tariff Extension

Retrieved on: 
Tuesday, January 11, 2022 - 11:00am

The Government has appealed a decision last year by the U.S. Court of International Trade that invalidated a presidential proclamation extending the original steel tariffs to nails and other derivative products.

Key Points: 
  • The Government has appealed a decision last year by the U.S. Court of International Trade that invalidated a presidential proclamation extending the original steel tariffs to nails and other derivative products.
  • Foreign nail makers, including Oman Fasteners, and U.S. distributors, including PrimeSource Building Products, then challenged the extension of tariffs to nails and won favorable judgments last April.
  • The Biden Administration appealed to the U.S. Court of Appeals for the Federal Circuit, to which the American Steel Nail Coalition addressed its Amicus brief today.
  • That brief made three basic arguments:
    First, "Proclamation 9980 has had a positive impact on the domestic steel nails industry, and thus, on American steel production and capacity utilization generally."

FDA Pre-Submission Filed for Cardio inCode-SCORE

Retrieved on: 
Tuesday, January 11, 2022 - 7:30am

Cardio inCode-SCORE is an in-vitro diagnostic test that assesses an individual's combined genetic and clinical risk to predict and prevent cardiovascular disease ("CVD").

Key Points: 
  • Cardio inCode-SCORE is an in-vitro diagnostic test that assesses an individual's combined genetic and clinical risk to predict and prevent cardiovascular disease ("CVD").
  • Following extensive exchange of information and constructive discussions with the FDA, GENinCode has been invited by the FDA to file its Pre-Submission for Cardio inCode-SCORE.
  • The FDA views Pre-Submission as a structured process for managing and tracking interactions between manufacturers and the FDA about the application for approval or clearance, prior to final submission.
  • Matthew Walls, CEO of GENinCode Plc, said: "Despite the delays driven by the pandemic, the filing of the Cardio inCode FDA Pre-Submission marks the start of the U.S. regulatory approval pathway and ongoing preparation for the launch of Cardio inCode-SCORE later this year.

DGAP-News: McDade Products, LLC Joins Forces with G Medical Tests and Services to Provide U.S. Retailers with Millions of COVID-19 at-Home PCR Test Kits

Retrieved on: 
Monday, January 10, 2022 - 12:13pm

McDade Products is a division of McDade Group, a specialty sales, marketing, and distribution company serving the U.S. retail industry.

Key Points: 
  • McDade Products is a division of McDade Group, a specialty sales, marketing, and distribution company serving the U.S. retail industry.
  • McDade Products is now accepting orders for the co-branded LiveNow PCR Collection Kit, which will retail for $9.99.
  • The diagnostic PCR (polymerase chain reaction) test detects the presence or absence of SARS-CoV2, the virus that causes COVID-19.
  • On average, tests results are expected to be available online within 24 hours from the time the sample is received.

Award-winning Anura™ convenient and contactless health tracking comes to any web browser, anytime.

Retrieved on: 
Wednesday, January 5, 2022 - 2:00pm

TORONTO, Jan. 5, 2022 /PRNewswire/ --Today NuraLogix unveiled Anura Web, a browser-based version of its MedTech Breakthrough Award-winning contactless health and wellness personal measurement solution.

Key Points: 
  • TORONTO, Jan. 5, 2022 /PRNewswire/ --Today NuraLogix unveiled Anura Web, a browser-based version of its MedTech Breakthrough Award-winning contactless health and wellness personal measurement solution.
  • "Ease of access to personal health monitoring and improving people's lives everywhere is our aim with Anura Web," said Chief Executive Officer Marzio Pozzuoli.
  • With no additional software to install, Anura Web requires only a web browser to provide the same features of its app-based counterpart Anura.
  • Anura Web and Anura were developed in partnership by tech entrepreneur and investor, Marzio Pozzuoli, and Developmental Neuroscientist, Dr. Kang Lee.

ThermVac Develops Chemical Vapor Deposition Technologies for SiC, TaC, B4C and PYC

Retrieved on: 
Wednesday, January 5, 2022 - 7:37am

This is in line with the increasing demand for high-temperature heat resistant CVD components from high-tech industries such as semiconductor, solar power, mobile phones, aerospace and defense.

Key Points: 
  • This is in line with the increasing demand for high-temperature heat resistant CVD components from high-tech industries such as semiconductor, solar power, mobile phones, aerospace and defense.
  • ThermVac has built in-house pilot CVD equipment that can raise the temperature up to 2,400C.
  • In response to clients' various CVD equipment requirements, it conducts process tests in advance using pilot equipment along with the overall design of CVD equipment.
  • Thereby it enhances equipment reliability as well as provides the customers with basic process recipes that are essential for initial equipment operation.

Wejo Announces Wejo Neural Edge Processing Platform Streamlining Connected Vehicle Data and Driving Autonomous Vehicle Reality Forward

Retrieved on: 
Tuesday, January 4, 2022 - 9:30pm

With todays vehicles producing approximately 25 gigabytes of data per hour, and as vehicle technology advances adding more sensors, data filtering and neural edge processing technology is essential to reduce this overload and drive the industry forward.

Key Points: 
  • With todays vehicles producing approximately 25 gigabytes of data per hour, and as vehicle technology advances adding more sensors, data filtering and neural edge processing technology is essential to reduce this overload and drive the industry forward.
  • Wejo Neural EdgeTM enables the standardisation and centralisation of the data that comes from autonomous, electric and connected vehicles.
  • Further details about the availability of the Wejo Neural Edge Processing platform will come at a future date.
  • Wejo (NASDAQ: WEJO) is a global leader in connected vehicle data, revolutionising the way we live, work and travel by transforming and interpreting historic and real-time vehicle data.